Clinical Utility of Survivin (BIRC5), Novel Cardiac Biomarker, as a Prognostic Tool Compared to High-sensitivity C-reactive Protein, Heart-type Fatty Acid Binding Protein and Revised Lee Score in Elderly Patients Scheduled for Major Non-cardiac Surgery: A Prospective Pilot Study

BACKGROUND: Recent studies indicate that survivin (BIRC5) is sensitive to the existence of previous ischemic heart disease, since it is activated in the process of tissue repair and angiogenesis. The aim of this study was to determine the potential of survivin (BIRC5) as a new cardiac biomarker in t...

Full description

Saved in:
Bibliographic Details
Published in:J Med Biochem
Main Authors: Marković, Danica, Jevtović-Stoimenov, Tatjana, Ćosić, Vladan, Stošić, Biljana, Dinić, Vesna, Marković-Živković, Bojana, Janković, Radmilo J.
Format: Artigo
Language:Inglês
Published: Sciendo 2018
Subjects:
Original Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6294091/
https://ncbi.nlm.nih.gov/pubmed/30581346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/jomb-2017-0046
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items